Amedisys' (AMED) Q4 Earnings Miss Estimates, Margins Up [Yahoo! Finance]
Amedisys Inc (AMED)
Last amedisys inc earnings: 2/18 04:15 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.amedisys.com
Company Research
Source: Yahoo! Finance
The bottom line missed the Zacks Consensus Estimate by 9.6%. The quarter's adjustments include certain merger related expenses, clinical optimization and CEO transition costs. GAAP EPS in the fourth quarter was 59 cents, in line with the year-ago figure of 97 cents. For the full year, adjusted earnings were $4.30 per share, reflecting a 14.2% fall from the year-ago period. It lagged the Zacks Consensus Estimate by 4.2%. Net service revenues totaled $570.8 million, up 1.6% year over year. The top line surpassed the Zacks Consensus Estimate by 1.1%. Total revenues for 2023 were $2.24 billion, reflecting a 0.6% rise from the year-ago period. The figure lagged the Zacks Consensus Estimate by 3%. Segments in Detail Net service revenues from the Home Health Division totaled $358.9 million in the quarter, up 4.3% year over year. Within the segment, Medicare revenues of $221.1 million dropped 1.6% year over year. Non-Medicare revenues increased 14.7% to $137.8 million. Within
Show less
Read more
Impact Snapshot
Event Time:
AMED
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AMED alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AMED alerts
High impacting Amedisys Inc news events
Weekly update
A roundup of the hottest topics
AMED
News
- Amedisys (AMED) Q1 Earnings Surpass Estimates, Margins Rise [Yahoo! Finance]Yahoo! Finance
- Amedisys, Inc. (NASDAQ: AMED) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
- Amedisys, Inc. (NASDAQ: AMED) had its "neutral" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $101.00 price target on the stock.MarketBeat
- Compared to Estimates, Amedisys (AMED) Q1 Earnings: A Look at Key Metrics [Yahoo! Finance]Yahoo! Finance
- Amedisys Reports First Quarter 2024 Financial Results [Yahoo! Finance]Yahoo! Finance
AMED
Earnings
- 2/21/24 - Miss
AMED
Sec Filings
- 4/26/24 - Form 10-K/A
- 4/25/24 - Form 10-Q
- 4/24/24 - Form 8-K
- AMED's page on the SEC website